平安证券股份有限公司 关于南通江天化学股份有限公司 2024年度持续督导跟踪报告 | 保荐机构名称：平安证券股份有限公司 | 被保荐公司简称：江天化学 | | --- | --- | | 保荐代表人姓名：赵宏 | 联系电话：021-38633117 | | 保荐代表人姓名：杨丹丹 | 联系电话：021-38633117 | 一、保荐工作概述 | 1、保荐代表人变更及其理由 | 无 | | --- | --- | | 2、报告期内中国证监会和本所对保荐机构或者其保荐的公司采取监管 措施的事项及整改情况 | 无 | | 3、其他需要报告的重大事项 | 无 | （以下无正文） （此页无正文，为《平安证券股份有限公司关于南通江天化学股份有限公司 2024年度持续督导跟踪报告》之签字盖章页） | 项目 | 工作内容 | | --- | --- | | 1、公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次 | 0次 | | 数 | | | 2、督导公司建立健全并有效执行规章制 | | | 度的情况 | | | （1）是否督导公司建立健全规章制度 | ...

南通江天化学股份有限公司 2024 年度 内部控制审计报告 索引 内部控制审计报告 页码 1-1 信永中和会计师事务所 北京市东城区朝阳门北大街 8 号官华大厨 A 座 9 层 +86 (010) 6554 2288 XYZH/2025SUAA2B0045 南通江天化学股份有限公司 南通江天化学股份有限公司董事会: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计 了南通江天化学股份有限公司 (以下简称江天化学公司 ) 2024 年 12 月 31 日财务报告内 部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》 、《企业内部控制应用指引》 、《企业内部控制评 价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是江天化学公司董事 会的责任。 内部控制审计报告 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审计意 见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于情况的 变化可能导致内部控制变得不恰当,或对控制政策和程序 ...

2024 年度 非经营性资金占用及其他关联资金往来的 南通江天化学股份有限公司 专项说明 | 蒙引 | 页码 | | --- | --- | | 专项说明 | 1-2 | | 非经营性资金占用及其他关联资金往来情况汇总表 | 1-1 | 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查 报告编码:京25DB4Z4BW | | | 北京市东城区朝阳门北大街 出示 做 一十分 日本 名 分 8号雷华大厦A座9房 关于南通江天化学股份有限公司 2024 年度非经营性资金占用及其他关联资金往来的专项说明 为了更好地理解江天化学公司 2024 年度非经营性资金占用及其他关联资金往来情 况汇总表,汇总表应当与已审计的财务报表一并阅读。 XYZH/2025SUAA2B0043 南通江天化学股份有限公司 本专项说明仅供江天化学公司 2024年度报告披露之目的使用,未经本事务所书面 同意,不得用于其他任何目的。 南通江天化学股份有限公司全体股东: 我们按照中国注册会计师审计准则审计了南通江天化学股份有限公司(以下简称江 天化学公司)2024 年度财务报表,包括 20 ...

南通江天化学股份有限公司 2024 年度 募集资金年度存放与使用情况鉴证报告 | 索引 页码 | | --- | | 鉴证报告 | | 关于募集资金 2024 年度存放与使用情况的专项报告 - 1-11 | 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn】 码 · 京25 群系自己 信永中和会计师事务所| 北京市东城区朝阳门北大街 8 号富华大厦 A座 9 层 ShineW untants 9/F Block A Fu Hua Mansio No 8 Chaovangmen Beidaiie Donacheng District, Beijing 100027 P R China 86 /010) 6554 7190 募集资金年度存放与使用情况鉴证报告 XYZH/2025SUAA2B0044 南通江天化学股份有限公司 南通江天化学股份有限公司全体股东: 我们对后附的南通江天化学股份有限公司(以下简称江天化学公司)关于募集资金 2024 年度存放与使用情况的专项报告(以下简称募集资金年度存放与使用情况专项报 告)执行了鉴证工作。 江天化学公司管理层的责任是按 ...

关于南通江天化学股份有限公司 2024 年度内部控制自我评价报告的核查意见 平安证券股份有限公司（以下简称平安证券或保荐机构）作为南通江天化学 股份有限公司（以下简称江天化学或公司）首次公开发行股票并在创业板上市的 保荐机构，根据《证券发行上市保荐业务管理办法》《企业内部控制基本规范》 《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作》等相关规定，就江天化学 2024 年度 内部控制相关情况进行了核查，发表意见如下： 一、本保荐机构进行的核查工作 保荐机构通过审阅《南通江天化学股份有限公司 2024 年度内部控制自我评 价报告》，查阅公司 2024 年度内部控制审计报告，公司股东大会、董事会、监 事会等会议文件以及各项业务和管理规章制度，公司重大合同及财务报表，现场 检查等方式，对公司 2024 年度内部控制制度的执行情况进行了核查。 二、内部控制评价工作情况 公司已经建立起一套比较完整且运行有效的内部控制体系，从公司层面到各 业务流程层面均建立了系统的内部控制及必要的内部监督机制，为公司经营管理 的合法合规、资产安全、财务报告及相关信息的真实完 ...

平安证券股份有限公司 关于南通江天化学股份有限公司 2024 年度募集资金存放与使用情况的核查意见 平安证券股份有限公司（以下简称平安证券或保荐机构）作为南通江天化学 股份有限公司（以下简称江天化学或公司）首次公开发行股票并在深圳证券交易 所创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券 交易所创业板股票上市规则》和《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》等有关规定，就江天化学 2024 年度募集资金存 放与使用相关情况进行了核查，发表意见如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于同意南通江天化学股份有限公司首次公开 发行股票注册的批复》（证监许可[2020]3213 号）同意注册，公司首次公开发行 人民币普通股（A 股）2,005 万股，每股面值人民币 1.00 元，发行价格为 13.39 元，募集资金总额为 268,469,500.00 元，由保荐机构扣除保荐承销费用 28,500,000.00 元（不含增值税）后的余额 239,969,500.00 元，并扣除其他发行 费 用 11,491, ...

Financial Performance - The company's revenue for Q1 2025 was CNY 350,419,768.39, representing a 104.57% increase compared to CNY 171,299,011.23 in the same period last year[4] - Net profit attributable to shareholders decreased by 93.42% to CNY 818,770.12 from CNY 12,446,146.76 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 97.64% to CNY 293,160.31 from CNY 12,396,405.64 in the previous year[4] - The total profit for the current period is 1,990,844.47, down from 16,465,959.92 in the previous period, indicating a decrease of about 87.9%[16] - The operating profit for the current period is 1,790,031.39, compared to 16,462,159.92 in the previous period, reflecting a decline of approximately 89.1%[16] - The basic and diluted earnings per share for the current period are both 0.0057, a significant drop from 0.0862 in the previous period[17] - The total comprehensive income for the current period is 818,770.12, down from 12,446,146.76 in the previous period, reflecting a decrease of about 93.4%[17] Cash Flow - The net cash flow from operating activities improved by 181.46%, reaching CNY 22,375,298.74 compared to a negative CNY 27,468,437.33 in the same period last year[4] - The cash flow from operating activities for the current period is 22,375,298.74, a significant improvement from a negative cash flow of -27,468,437.33 in the previous period[18] - The cash flow from investing activities shows a net outflow of -325,984,560.51, worsening from -128,415,133.47 in the previous period[19] - The cash flow from financing activities for the current period is 31,923,461.48, down from 110,749,830.30 in the previous period, indicating a decrease of approximately 71.1%[19] - The company received cash from sales of goods and services totaling 341,691,338.76, a significant increase from 138,994,616.50 in the previous period, representing an increase of about 146.0%[18] Assets and Liabilities - Total assets decreased by 11.02% to CNY 1,956,761,840.45 from CNY 2,199,096,987.89 at the end of the previous year[4] - Cash and cash equivalents decreased to ¥404,896,860.25 from ¥675,806,644.32, reflecting a decline of 40.0%[12] - Accounts receivable decreased to ¥132,349,646.04 from ¥145,470,217.47, a reduction of 9.0%[12] - Inventory levels decreased to ¥223,940,373.54 from ¥268,017,043.50, representing a decline of 16.4%[12] - Total liabilities decreased to ¥992,296,431.87 from ¥1,236,221,985.47, a reduction of 19.8%[14] Market and Competition - The company attributed the significant decline in net profit to intense market competition and price reductions across various products[6] - The increase in revenue was partly due to the consolidation of a new subsidiary, which contributed to the revenue growth[6] - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided data[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,815[8] - The gross profit margin for the current period is approximately 0.12%, compared to a margin of 0.42% in the previous period, indicating a decrease in profitability[15]

Financial Performance - The company's operating revenue for 2024 was ¥688,379,172.65, a decrease of 2.92% compared to ¥709,117,773.22 in 2023[16]. - Net profit attributable to shareholders for 2024 reached ¥297,735,338.47, representing a significant increase of 334.35% from ¥68,546,910.88 in 2023[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥40,087,061.25, down 39.48% from ¥66,242,567.24 in 2023[16]. - The net cash flow from operating activities was ¥16,328,708.96, a decline of 81.27% compared to ¥87,183,491.98 in 2023[16]. - Basic earnings per share for 2024 were ¥2.0625, an increase of 334.39% from ¥0.4748 in 2023[16]. - Total assets at the end of 2024 amounted to ¥2,199,096,987.89, a 119.79% increase from ¥1,000,529,837.52 at the end of 2023[16]. - The company reported a total of ¥257,648,277.22 in non-recurring gains for 2024, compared to ¥2,304,343.64 in 2023[22]. - The weighted average return on equity for 2024 was 36.11%, up from 10.36% in 2023[16]. - The company achieved revenue of CNY 688.38 million, a decrease of 2.92% compared to the previous year, while net profit reached CNY 297.74 million, an increase of 334.35% year-on-year[42]. - The company's cash flow from operating activities was CNY 16.33 million, down 81.27% from the previous year[42]. Dividend Distribution - The company plans to distribute a cash dividend of 0.90 RMB per 10 shares to all shareholders, based on a total of 144,360,000 shares[3]. - The profit distribution plan for 2024 includes a cash dividend of 0.90 CNY per 10 shares, amounting to 12,992,400 CNY (including tax), with no stock dividends or capital reserve transfers[153]. - The cash dividend distribution plan aligns with the company's articles of association and has been approved by the board and shareholders[152]. - The company plans to distribute a cash dividend of 1.45 CNY per 10 shares, totaling 20,932,200 CNY (including tax) based on a total share capital of 144,360,000 shares for the 2023 fiscal year[151]. Risk Management - The company emphasizes the importance of risk awareness regarding macroeconomic fluctuations, raw material volatility, and major asset restructuring[3]. - The report outlines potential risks in its future development outlook, particularly in areas such as project construction and accounts receivable[3]. - The company reduced major risks from 17 in 2023 to 10, and the number of significant hazards decreased from 4 to 1[33]. - The company is implementing measures to manage accounts receivable risks, including strengthening collection mechanisms and optimizing contract review processes[104]. - Safety and environmental risks are present due to the nature of raw materials and production processes, prompting the company to enhance safety management and compliance measures[101]. Acquisitions and Investments - The company acquired 100% equity of Sanhe Yajia Fine Chemicals (Nantong) Co., Ltd., which is expected to significantly impact its "one body, two wings" development strategy[27]. - The company completed the acquisition of 100% equity in San Daya, expanding its business into superabsorbent resin, which enhances its product structure and customer diversification[44]. - The company completed the acquisition of 100% equity in SDP Global Co., Ltd. for cash, with the transaction approved on December 4, 2024[198]. - The newly acquired subsidiary, Nantong San Daye Fine Chemicals Co., Ltd., was included in the company's consolidated financial statements as of the end of the reporting period[198]. Research and Development - The company has established 6 R&D projects for 2024, with 29 dedicated and part-time employees involved, accounting for 13.81% of the total workforce[33]. - The company is focused on expanding its market presence by leveraging customer value and technological innovation[36]. - The company is actively developing new products, including high-purity chloromethane and high water-absorbent resins[37]. - The company plans to enhance R&D efforts with multiple products in development, aiming to launch new products based on customer demand in 2025, while also establishing a new R&D center in the southern region[99]. Safety and Environmental Compliance - The company has established a comprehensive safety, environmental protection, and occupational health management system, achieving certifications such as ISO9001, ISO14001, and ISO45001[158]. - The company is classified as a key pollutant discharge unit by environmental protection authorities, adhering to various environmental regulations and standards[168]. - The company's wastewater discharge standards include CODcr ≤ 500 mg/L, ammonia nitrogen ≤ 45 mg/L, and total phosphorus ≤ 8 mg/L, all of which are in compliance with national standards[169]. - The company has implemented upgrades to pollution control facilities, ensuring stable compliance with emission standards[171]. - The company has not experienced any major environmental pollution incidents during the reporting period[171]. Corporate Governance - The company has a total of 9 board members, including 3 independent directors, complying with legal and regulatory requirements[111]. - The supervisory board consists of 5 members, with 2 being employee representatives, and held 7 meetings during the reporting period[112]. - The company maintained a 99.4% response rate to investor inquiries on the interactive platform, ensuring timely communication and information transparency[115]. - The company operates independently from its controlling shareholder in terms of assets, personnel, finance, organization, and business, ensuring a complete and independent operational capability[116]. - The company has established an independent financial department with a clear financial management system, allowing for independent financial decision-making[116]. Employee Management - The company has a total of 374 employees at the end of the reporting period, with 210 in the parent company and 164 in major subsidiaries[148]. - The company has a total of 287 employees with a bachelor's degree or higher, representing approximately 76.7% of the total workforce[148]. - The company emphasizes internal training programs to enhance employee skills and overall company development potential[150]. - The company has implemented a salary policy based on base salary and performance bonuses, with adjustments made according to industry standards[149]. Financial Management - The company has a robust project management system in place, ensuring strict adherence to decision-making procedures and budget controls[158]. - The company has established a detailed management plan for the raised funds to ensure legal and compliant usage, aiming to improve financing structure and profitability[192]. - The company has committed to fulfilling its obligations regarding immediate return measures and ensuring compliance with regulatory requirements[196]. - The company has engaged Xinyong Zhonghe Accounting Firm for internal control auditing, with total audit fees amounting to 480,000 RMB, including 360,000 RMB for financial statement audit and 120,000 RMB for internal control audit[199]. Market Expansion - The company is actively expanding its market by developing new applications for triazine and exploring downstream derivatives[33]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $100 million allocated for potential mergers[132]. - Market expansion plans include entering two new regions, which are projected to increase market share by 10%[131]. Compliance and Legal Matters - The company has not faced any administrative penalties related to environmental issues during the reporting period[174]. - The company has not reported any major lawsuits or administrative penalties in the last three years[179]. - The company has committed to providing accurate and complete information regarding the transaction as per regulatory requirements[179]. - The company has ensured compliance with the disclosure requirements for the chemical industry as mandated by the Shenzhen Stock Exchange[176].

经核查，独立董事宋义虎、郁东、吴建新的任职经历以及签署的相关自查文 件，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观判 断的关系，不存在影响独立董事独立性的情况，符合《上市公司独立董事管理办 法》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市公司规范运作》 中对独立董事独立性的相关要求。 南通江天化学股份有限公司董事会 关于独立董事独立性情况评估的专项意见 南通江天化学股份有限公司（以下简称"公司"）董事会根据《上市公司独 立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市 公司规范运作》等要求，就公司在任独立董事宋义虎、郁东、吴建新的独立性情 况进行评估并出具如下专项意见： 南通江天化学股份有限公司董事会 2025 年 4 月 16 日 ...

第一章 总 则 第一条 为适应南通江天化学股份有限公司（以下简称"公司"）战略发展需要，增 强公司核心竞争力，确定公司发展规划，健全投资决策程序，提高重大投资决策的效益 和决策的质量，完善公司治理结构，实现公司与环境、社会的协调发展，根据《公司法》 《证券法》《上市公司治理准则》《企业内部控制规范》《深圳证券交易所上市公司自律 监管指引第 2 号—创业板上市公司规范运作》和《公司章程》的相关规定，公司董事会 设立战略与可持续发展委员会，并制定本工作细则。 第二条 董事会战略与可持续发展委员会是董事会设立的专门工作机构，负责对公 司长期发展战略规划、重大投资决策和可持续发展战略进行可行性研究并提出建议，向 董事会报告工作并对董事会负责。 第二章 人员组成 第三条 战略与可持续发展委员会成员由五名董事组成，其中应至少包括独立董事 一名。 第四条 战略与可持续发展委员会委员由董事长、二分之一以上独立董事或者三分 之一以上董事提名，由董事会选举产生。 第五条 战略与可持续发展委员会设召集人一名，由董事长担任，负责主持委员会 工作。 第六条 战略与可持续发展委员会委员任期与董事会董事一致，委员任期届满，连 选可以连任。 ...